T2 Biosystems, Inc.·4

Feb 20, 4:00 PM ET

Gibbs Michael Terrence 4

4 · T2 Biosystems, Inc. · Filed Feb 20, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Gibbs Michael Terrence
General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-20+40106 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-204040 total
    Common Stock (40 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On February 20, 2022 the reporting person was granted 120 RSU's that vest annually in three substantially equal installments commencing on February 20, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4